Background The study focuses on three questions related to the clinical usefulness of microdialysis in severe brain trauma:
Introduction
The technique of microdialysis was originally developed to monitor neurotransmitters in the animal brain during experimental conditions [1] . A microdialysis catheter intended for the human brain, an infusion pump, an analyser for bedside analysis of the dialysate and display of biochemical variables related to cerebral energy metabolism was presented in 1995. This year the microdialysis technique was also introduced as a clinical routine at the Department of Neurosurgery, Lund University Hospital. The study presented here includes all patients with severe traumatic brain injuries (TBI) monitored with microdialysis during the period 1995-2009.
More than 300 articles with data obtained from intracerebral microdialysis have been published in patients with severe TBI. However, comprehensive information regarding cerebral energy metabolism has previously been presented in only two large series of TBI patients. One of these showed that variables obtained during microdialysis exhibited a poor correlation to global variables like intracranial pressure (ICP) and cerebral perfusion pressure (CPP) as well as clinical outcome, while autocorrelation was high for all biochemical markers [2] . The second large study had a conflicting conclusion claiming that increase in interstitial lactate/pyruvate (LP) ratio was an independent marker of poor clinical outcome [3] . As intracerebal microdialysis gives biochemical information from a very small volume of tissue a general correlation between the biochemical patterns obtained and clinical outcome would not be expected. In both large studies there is a lack of information regarding the conditions necessary for obtaining such correlations. Further, there is a need of deeper understanding of the information obtained from the LP ratio.
The LP ratio obtained from microdialysis reflects cerebral cytoplasmatic redox state [4] [5] [6] . The latter is determined by the oxidative metabolism, which in turn is primarily dependent on adequate cerebral perfusion/oxygen delivery and mitochondrial function. Under clinical conditions an increase in LP ratio is mainly observed during ischaemia and postischaemic mitochondrial dysfunction. In experimental and clinical studies we have recently shown that the pattern of the biochemical variables obtained during routine microdialysis may discriminate between these two conditions [7] [8] [9] .
In the present study we describe: (1) how frequently a perturbation of cerebral energy metabolism is observed in patients with severe TBI in four different types of lesions, (2) how often the pattern of the biochemical variables indicates cerebral ischaemia and mitochondrial dysfunction respectively and how often transitions between these two patterns occur, and (3) how these biochemical patterns relate to mortality in the various diagnostic groups.
Materials and methods
In 1991, the Ethical Committee of Lund University Medical Faculty approved the use of microdialysis with multiple intracerebral catheters as a standard clinical technique in neurocritical care. In 1995, microdialysis was introduced as part of clinical routine in patients with severe TBI. From the beginning, bedside analysis and display of chemical variables related to cerebral energy metabolism was included. The present study is a retrospective analysis of data collected prospectively in all patients with severe TBI monitored with microdialysis during the period of November 1995 to August 2009 at the Department of Neurosurgery, Lund University Hospital, Sweden.
The study includes 213 consecutive patients with altogether 342 intracerebral microdialysis catheters. The mean age ± SD of the patients was 39 ± 19 years. All patients had an estimated post-resuscitation Glasgow Coma Scale (GCS) sum score <8 (GCS motor score <5) [10] . Basic data regarding the patients, the diagnostic groups and the number of microdialysis catheters in the different groups are given in Table 1 . The patients were classified in four groups according to the type of lesion. Patients defined as extradural haematoma (EDH), acute subdural haematoma (SDH) or focal cerebral haemorrhagic contusion (CHC) were all acutely treated surgically with evacuation of the mentioned type of lesion. In patients with a no mass lesion (NML), evacuation of a focal mass was not necessary. In all patients, ICP was continuously monitored from an intraventricular catheter [11] . Mean arterial pressure (MAP) was continuously monitored from an intraarterial line and CPP was calculated as MAP -ICP. All patients were kept sedated and intubated with controlled normoventilation during the monitored period. Neurocritical care was conducted according to the principles developed and evaluated at the Department of Neurosurgery, Lund University Hospital (BLund concept^) [12, 13] . Clinical outcome is in the present study described as mortality within 6 months after trauma. As transitions between the two categories of ischaemia and mitochondrial dysfunction were observed patients exhibiting a change from ischaemia to mitochondrial dysfunction were classified as mitochondrial dysfunction and vice versa.
Intracerebral microdialysis
Microdialysis was performed utilising CMA 70 or 71 catheters (cut-off 20 and 100 kDa, respectively; CMA Micodialysis, Stockholm, Sweden) as described previously [13, 14] . The microdialysis catheters were perfused (Perfusion Fluid, CMA Microdialysis) at a rate of 0.3 μl/min and the perfusates were collected in capped microvials at 1-h intervals. The samples were immediately analysed for glucose, pyruvate, lactate, glutamate and glycerol utilising conventional enzymatic techniques (CMA 600 or ISCUS Microdialysis Analyzer) and the results were displayed on a bedside monitor. The calculated LP ratio was used for evaluation of the cytoplasmatic redox state. All data obtained from cerebral microdialysis were integrated bedside with global biochemical and physiological data utilising a specially developed computer program (ICU-pilot; CMA Microdialysis, Stockholm, Sweden). In the present study, we report the biochemical data obtained during the initial 96 h after trauma. During this time period altogether about 150,000 bedside biochemical analyses were conducted and displayed bedside.
In patients treated with open surgical evacuation (ECH, SDH, CHC) one microdialysis catheter was usually inserted into the vicinity of the focal lesion-Bbiochemical penumbra [ 15] . In 105 of these patients, one, two or three additional catheters were inserted into the ipsilateral or contralateral hemisphere (Table 1 ). In patients with NMLs, one microdialysis catheter was introduced through a separate burr hole a few centimetres distant from the intraventricular catheter. In four of these patients, a second microdialysis catheter was also inserted into the contralateral hemisphere.
Five patients, who on admission were classified as GCS 3 with dilated non-reacting pupils (one EDH, four SDHs), died due to an intractable increase in ICP within 24 h of trauma.
Data from these and two other patients who died within 4 days after trauma are excluded from the figures showing the time course of the biochemical changes during the studied period of 96 h but are included in the tables comparing the biochemical patterns in cerebral ischaemia/mitochondrial dysfunction and mortality.
Cerebral biochemical variables
Normal reference levels for the studied biochemical variables were defined from data obtained in un-anaesthetised normal human brain utilising identical microdialysis and analytical techniques [14] . In accordance with conventional principles in clinical chemistry, normal range was defined as normal mean level ± 2 SDs. As the LP ratio in normal human brain is 23 ± 4 [14] , the upper normal level for cerebral LP ratio was in the present study set at 30. For cerebral interstitial pyruvate concentration, 70 μmol/L was defined as the lower normal level. In accordance with recent experimental and clinical studies LP ratio >30 at a pyruvate concentration ≥70 μmol/L was interpreted as a biochemical pattern indicating mitochondrial dysfunction, while LP ratio >30 simultaneously with pyruvate <70 μmol/L was interpreted as a biochemical pattern indicating ischaemia [7] [8] [9] . An increase in interstitial glutamate concentration above normal was interpreted as a sign of perturbation of cerebral energy metabolism resulting in impaired astrocytic re-uptake of glutamate [16, 17] . Increase in glycerol above normal range was interpreted as an indication of degradation of cellular membranes with liberation of free fatty acids and glycerol [18, 19] .
Patients were classified as neither ischaemia nor mitochondrial dysfunction if they during the whole study period of 96 h had LP ratio ≤30. Biochemical data for patients classified as ischaemia or mitochondrial dysfunction are given selectively for the time periods the definitions given above were fulfilled. For the diagnosis of these two conditions, the biochemical pattern defined above should have been obtained during three consecutive hours or more. Approximately 77,000 of the total number of analyses are included in the description of these three groups.
Statistics
Data for groups of patients are given as mean ± SD in Figs. 3, 4 and 5 and as median and interquartile range (q1-q3) in Tables 1 and 2 . Statistical comparisons were performed utilising unpaired t-test.
Results
Age distribution of the patients and the number of functioning microdialysis catheters in the four diagnostic groups are given in Table 1 . Patients in the diagnostic groups of SDH and CHC were significantly older than those in the groups of EDH (p < 0.05) and NML (p < 0.001). Table 2 gives the levels of the biochemical variables obtained from all microdialysis catheters for the three diagnostic groups of ischaemia, mitochondrial dysfunction and LP ratio ≤30 (normal aerobic metabolism). In the table, median level and interquartile range represent data from the total number of samples (N samp ) and analyses of each variable from all inserted microdialysis catheters. The levels of these variables obtained in normal human brain are shown as in reference [14] .
The statistical comparisons were performed from the median levels of the variables obtained in each catheter during each episode of ischaemia (N epis = 41), mitochondrial dysfunction (N epis = 112) and LP ratio ≤30 (N epis = 130), respectively. Due to the definition of the inclusion criteria the levels of pyruvate and the LP ratio differed between these two groups as well as between these groups and patients with LP ratio ≤30. Accordingly, the LP ratio and pyruvate level were not included in the statistical comparisons. The levels of glutamate and glycerol were during ischaemia significantly higher than during mitochondrial dysfunction, while glucose was higher in the latter group. In both the ischaemia and mitochondrial dysfunction groups, lactate, glutamate and EDH extradural haematoma, SDH acute subdural haematoma, CHC cerebral haemorrhagic contusion, NML no mass lesion-patients not treated with surgical evacuation, MD microdialysis
Age is given as median and interquartile range (q1-q3)
glycerol were significantly higher (p < 0.001) and glucose was significantly lower (p < 0.001) when compared with the LP group of LP ratio ≤30 (statistical comparisons not shown in the table) . Transition between the two categories of ischaemia and mitochondrial dysfunction was observed in a total of 40 catheters. In 22 of these cases, the transition occurred from ischaemia to mitochondrial dysfunction. In catheters with an observed transition from ischaemia to mitochondrial dysfunction, mean pyruvate level increased from 46 ± 21 (N = 468) to 148 ± 43 μmol/L (N = 908). In catheters with transition from mitochondrial dysfunction to ischaemia, mean pyruvate level decreased from 166 ± 115 (N = 327) to 40 ± 25 μmol/L (N = 349). The number of observed transitions and the distribution between the four diagnostic groups is shown in Table 3 . The transitions were usually clearly delineated as illustrated in Figs. 1 and 2. In Fig. 1 (transition from mitochondrial dysfunction to ischaemia), a rapid decrease in pyruvate from about 200 μmol/L to below 20 μmol/L simultaneously with a slow increase in the concentration of lactate resulted in a very pronounced increase in LP ratio from an initially moderately increased level (50-60). The simultaneously occurring change in glucose level is also shown. A late increase in glucose occurred, although CPP remained below 20 mmHg. In Fig. 2 (transition from ischaemia to mitochondrial dysfunction), the increase in pyruvate from a very low level (40-60 μmol/L) to a high normal level at an unchanged high level of lactate (9-12 mmol/L) is reflected in a decrease in LP ratio which, however, remained above normal at a level of about 50-60. The simultaneous increase in glucose concentration is also shown. These biochemical changes coincided with an increase in CPP from approximately 50 to 75 mmHg.
The changes over time for all biochemical variables measured bedside during the studied period of 96 h are shown (mean and standard deviation [SD]) in Figs. 3, 4 and 5. In these figures, data obtained from seven patients who died during this time period (one EDH; six SDHs) are excluded. The SD for each variable is only shown in one direction.
In the EDH group, the LP ratio remained close to normal during the study period (Fig. 3a) . Also in the NML group, the LP ratio was relatively close to normal (Fig. 3b) . In the CHC group, the LP ratio was initially very high and exhibited a slow decline towards normality during the study (Fig. 3b) . In the SDH group, the LP ratio was initially moderately elevated and exhibited a transient pronounced increase during the Ischaemia defined as LP ratio >30 at pyruvate <70 μmol/L. Mitochondrial dysfunction defined as LP ratio >30 at pyruvate ≥70 μmol/L. Reference levels for the biochemical variables are based on data obtained from normal human brain [14] N samp refers to the number of microdialysis samples in each group
Statistical comparisons between the median levels of lactate, glucose, glutamate and glycerol during the episodes of ischaemia (N epis = 41) and mitochondrial dysfunction (N epis = 112) are shown (***p < 0.001, **p < 0.002) (Fig. 3a) . During this period there was also a distinct increase in SD, indicating that a very marked secondary increase in LP ratio occurred in some of these patients. The changes in glutamate exhibited a pattern similar to the pattern in the LP ratio (Fig. 4a, b) . In the EDH and NML groups, glutamate remained relatively close to normal. In the SDH and CHC diagnostic groups, glutamate concentration was initially markedly increased and in the SDH group a secondary increase was observed about 20-60 h after trauma (Fig. 4a) . Intracerebral glycerol was also considerably elevated in the groups of SDH and CHC (Fig. 5a, b) and a secondary increase in glycerol was observed in the SDH group (Fig. 5a ). Table 4 gives the total number of hours the biochemical patterns indicated ischaemia, mitochondrial dysfunction and a normal LP ratio, respectively, in the four diagnostic groups. In the total material, the biochemical pattern of ischaemia was observed during 6 % of the study period, while the pattern of mitochondrial dysfunction was obtained during 32 % of the time. Table 4 also shows mortality within 6 months of trauma. In the total group of 213 patients, mortality was 17 %. Mortality was highest in the SDH group (29 %) and lowest in the NML group (9 %). In the total material mortality was higher in patients with a biochemical pattern of ischaemia (38 %) than in those with signs of mitochondrial dysfunction or a normal LP ratio (9 and 13 %, respectively). In the SDH and NML diagnostic groups, mortality was markedly elevated for patients with a biochemical pattern of ischaemia (73 and 33 %, respectively). The biochemical pattern of mitochondrial dysfunction appeared to be associated with increased mortality only in patients with SDH (40 %). In patients classified as CHC, ischaemia and mitochondrial dysfunction was not related to increased mortality.
Discussion
Multimodal monitoring aims at early detection of secondary physiological and biochemical deterioration that may affect clinical outcome. If the processes underlying the deterioration are identified and understood, appropriate therapeutic interventions may be instituted. Correct clinical application and interpretation of intracerebral microdialysis necessitates substantial knowledge of the advantages and the limitations of the technique. First, the metabolic pathways related to cerebral energy metabolism are complex and the interpretation of the biochemical patterns observed must be based on known biochemical patterns obtained under defined experimental conditions. Normal limits for the variables studied must be based on our present knowledge of the variations occurring in normal human brain under physiological conditions. Second, changes over time for the observed chemical patterns are often more important than the absolute levels of individual variables. Information regarding such changes is difficult to convey in scientific publications but is often necessary for the clinical interpretation. Third, as the biochemical information originates from a very small volume of tissue, it is usually not known whether this information is representative of the global cerebral energy state. When microdialysis is intended to give an early warning of threatening deterioration, the catheter is positioned in the especially vulnerable Bpenumbra zoneÊ surrounding focal lesions [15] . In this situation a correlation to global variables and clinical outcome would be expected only if the Bpenumbra zone^includes a major part of a hemisphere.
Interpretation of biochemical data
The cerebral energy state is entirely dependent on oxidative metabolism. The cerebral cytoplasmatic redox state is determined by mitochondrial oxidative metabolism which conventionally is described by the lactate dehydrogenase equilibrium as reflected in the LP ratio [4] [5] [6] . Lactate and pyruvate are water soluble. However, due to monocarboxylate transporters (MCTs), they equilibrate rapidly across cellular membranes. Out of the total family of 14 members, three isoforms (MCT1, MCT2, MCT4) have been described in the brain [20] . The driving force for the transport of the monocarboxylates is obtained from the differences in concentration on both sides of the cellular membranes. As lactate and pyruvate rapidly equilibrate over the cell membrane, the LP ratio obtained during cerebral microdialysis may be used as a measure of cytoplasmatic redox state [6] . Available data indicate that LP ratio obtained from microdialysis of un-anesthetised normal human brain is 23 ± 4 [14] . Based on conventional principles accepted in clinical chemistry, we defined an LP ratio of 30 as the upper limit for normal aerobic metabolism. An increase in LP ratio above normal indicates compromised oxidative metabolism, which in TBI patients is generally due to ischaemia (insufficient blood supply) or mitochondrial dysfunction [21] . In cerebral ischaemia the increase in LP ratio is associated with a very low pyruvate level, while in mitochondrial dysfunction pyruvate level is increased or remains within normal limits [8] . Accordingly, these two conditions can be diagnosed and separated bedside by utilising routine cerebral microdialysis. The patterns of ischaemia and mitochondrial dysfunction were defined in accordance with recent experimental and clinical studies [7] [8] [9] . Mortality in four diagnostic groups: extradural haematoma (EDH); acute subdural haematoma (SDH); cerebral haemorrhagic contusion (CHC); no mass lesion (NML) denotes patients not treated with surgical evacuation. Mortality is also given separately for the biochemical subgroups defined as ischaemia (Isch), mitochondrial dysfunction (Mit dysf) and normal aerobic metabolism (LP ratio ≤30) within each diagnostic group
As mentioned previously, normal ranges for the biochemical variables were defined in accordance with conventional principles in clinical chemistry. An LP ratio >30 at a pyruvate concentration ≥70 μmol/L was interpreted as mitochondrial dysfunction, while LP ratio >30 simultaneously with pyruvate <70 μmol/L was interpreted as ischaemia. Like in all clinical situations, these limits should not be regarded as definite thresholds and the information obtained by cerebral microdialysis should always be related to other biochemical, physiological and clinical information. Table 2 shows that in TBI patients classified according to these principles and an LP ratio ≤30 (normal aerobic metabolism), all biochemical variables were close to the levels obtained in normal human brain [14] . This pattern of normal aerobic metabolism during the whole study period was obtained in approximately 62 % of all analysed samples. In both the ischaemia (6 % of the study period) and mitochondrial dysfunction groups (32 % of the study period), glutamate and glycerol were significantly elevated, indicating insufficient energy metabolism, leading to cell membrane degradation. These indications of compromised cerebral energy metabolism and signs of degradation of membranes were significantly more pronounced in the ischaemia group than in the mitochondrial dysfunction group.
The possibility to identify and separate ischaemia and mitochondrial dysfunction bedside by microdialysis has clinical implications. When ischaemia is diagnosed, an increase in cerebral perfusion pressure (cf. Fig. 2 ) or therapy improving microcirculation has been shown to normalise the biochemical pattern [22] . In patients with mitochondrial dysfunction, drugs supposed to improve mitochondrial function can be tested and microdialysis can be used to evaluate their biochemical effects (e.g. cyclosporin A, ethyl-pyruvate) [23] [24] [25] .
Transitions between ischaemia and mitochondrial dysfunction
During experimentally induced mitochondrial dysfunction the biochemical pattern is identical to the pattern in the mitochondrial dysfunction group in the present study [7] [8] [9] . In experimental studies it has been shown that transient ischaemia causes mitochondrial dysfunction [26] [27] [28] . However, although many acute and chronic neurologic conditions seem to be associated with mitochondrial dysfunction, the consequences of this disorder are not well-known in brain trauma or other acute and chronic cerebral diseases [29] . In addition to other possible pathophysiological consequences, mitochondrial dysfunction might increase the risk of compromised energy metabolism at a reduction of cerebral perfusion.
As illustrated in Figs. 1 and 2 , transitions between ischaemia and mitochondrial dysfunction are characterised by rapid changes in pyruvate concentration resulting in dramatic changes in the LP ratio. As shown in the figures glucose concentration may in both conditions vary considerably. During mitochondrial dysfunction glucose concentration has been shown to vary from normal to very low levels [7] [8] [9] 30] . During the period of ischaemia illustrated in Fig. 1 , glucose increased from a very low to a normal level, although CPP was extremely low (20 mmHg). The observation is explained by the fact that during a decrease in blood flow delivery of oxygen is critically compromised at a higher blood flow than glucose [6] . During the period of ischaemia shown in Fig. 1 , glutamate and glycerol increased to extremely high levels (>500 μmol/L and >2,000 μmo/L, respectively).
Biochemical pattern related to type of lesion
The differences between the time courses of the biochemical patterns obtained in different types of traumatic brain lesions have not been described previously. In patients with EDH and NML, the LP ratio was generally normal or close to normal with a relatively narrow SD (Fig. 3) . The higher mean LP ratio in the groups of SDH and CHC indicates that energy metabolism is generally more severely compromised in these patients. The high SD in both groups reflects a pronounced variability between patients. In particular, in the SDH group the increase in LP ratio after 24-48 h signals secondary adverse events (Fig. 3a) . In all groups the redox pattern is reflected in parallel changes in glutamate and glycerol. The observation indicates that the degree of compromised energy metabolism translates to the degree of tissue damage. The biochemical patterns observed is in agreement with the fact that patients with focal intracerebral mass lesions in general have worse outcome than patients with NML or EDH.
Intracerebral microdialysis and clinical outcome
As the microdialysis technique gives biochemical information from a very narrow zone surrounding the catheter a correlation between microdialysis data and clinical outcome should not be expected. By inserting multiple intracerebral microdialysis probes it has been shown that energy metabolism is severely compromised in the Bpenumbra zone^surrounding focal lesions while biochemistry in other parts of the brain remained close to normal [15] . Accordingly, intracerebral microdialysis would be expected to reflect local tissue outcome but not necessarily correlate to clinical outcome. A correlation between microdialysis/tissue outcome and clinical outcome would be expected only if the disturbance of cerebral energy metabolism is global or if the biochemical Bpenumbra zoneî ncludes a large part of a hemisphere.
In the present study mortality within 6 months was very high (73 %) in the SDH patients within the subgroup defined as ischaemia. In the corresponding subgroup in the CHC patients, mortality was remarkably low (13 %). In patients with normal aerobic metabolism (LP ratio ≤30), mortality was in these groups 14 % and 20 %, respectively. The high mortality in the ischaemia group in SDH patients is probably explained by the fact that the haematoma has affected energy metabolism in a large part of the hemisphere. In patients with CHC, a limited biochemical Bpenumbra zone^surrounds the focal lesion which is not representative of the hemisphere [15] . However, by monitoring deterioration of energy metabolism in this particularly vulnerable zone an early warning may be obtained. A change in therapy might under these conditions prevent the deterioration to spread to adjacent areas of the brain. Further, a normal LP ratio also reflects the energy state in a small volume of tissue which explains why in patients with CHC mortality was remarkably high in the group with LP ≤30 (Table 4) .
Under clinical conditions it may be difficult or impossible to decide whether the biochemical information obtained from microdialysis is focal or representative. Accordingly, it would be of value to develop a bedside technique that reveals global cerebral energy state as a complement to the conventional microdialysis method. One possibility might be to measure biochemical variables obtained from intraventricular microdialysis [31] . A second possibility which avoids the necessity to insert an intracerebral catheter was recently presented in an experimental study: evaluation of global cerebral energy state by placing a microdialysis catheter in the cerebral venous drainage (superior sagittal sinus) and measure the LP ratio [32] . This technique might also be used in patients where a global deterioration of cerebral energy metabolism is expected but it is for technical and ethical perspectives impossible to insert intracerebral catheters (e.g. extracorporeal circulation during open heart surgery, resuscitation after cardiac standstill).
BIschaemia-mitochondrial dysfunction^and the concept of Bmetabolic crisisÎ t has repeatedly been observed that in patients with TBI increased LP ratio is often not related to reduced cerebral blood flow and ischaemia [33, 34] . The concept of Bmetabolic crisis^has been defined as a low intracerebral glucose level and/or elevation in the LP ratio [34] . However, this concept is associated with certain problems. Firstly, it does not explain the biochemical or physiological background and can accordingly not lead to any specific therapeutic considerations. Secondly, the biochemical limits used to define metabolic crisis vary in different publications [33] [34] [35] .
The introduction of the two diagnostic groups of ischaemia and mitochondrial dysfunction circumvents these problems. In experimental studies it is well documented that ischaemia causes mitochondrial dysfunction [26] [27] [28] , it has been shown to occur in patients with brain trauma [36] , and the limits used for the separation of the two conditions is based on experimental and clinical studies [7] [8] [9] . Both conditions may be associated with a low intracerebral glucose level [8, 30] . Finally, the bedside diagnosis and separation of the two conditions is directly related to different therapeutic strategies [22] [23] [24] [25] .
Conclusions
In patients with severe traumatic brain injuries, compromised cerebral aerobic metabolism (LP ratio >30) was documented during 38 % of the study period. A biochemical pattern interpreted as mitochondrial dysfunction was more common than the pattern of ischaemia (32 % and 6 % of the study period, respectively). In patients with EDH and NML, aerobic metabolism was generally normal or close to normal; while in patients with SDH or CHC, it was often severely compromised. Compromised aerobic metabolism was translated to variables reflecting tissue damage (glutamate, glycerol). In SDH patients, microdialysis frequently revealed secondary adverse events occurring 24-48 h after trauma. In the total group of patients, mortality within 6 months was increased for patients exhibiting a biochemical pattern of ischaemia. In patients with impaired aerobic metabolism, increased mortality was observed in SDH, while patients with CHC did not exhibit a similar relationship. This difference is explained by the fact that perturbation of energy metabolism usually occurs in a large part of the hemisphere in SDH but is more localised to a Bpenumbra zone^in CHC patients. Ideally, the conventional intracerebral microdialysis technique should be supplemented by a technique revealing global cerebral energy state.
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